The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Path: Diffuse alveolar damage (DAD-pattern) (see also IL)
Publications
Amiodarone-induced multiple organ damage in an Alström syndrome patient with end-stage renal disease and hepatic cirrhosis.
CEN case reports. 2022;11(1):11-16
Severe amiodarone induced pulmonary toxicity.
Journal of thoracic disease. 2012;4(6):667-70
A rare case of acute diffuse alveolar hemorrhage following initiation of amiodarone: a case report.
Military medicine. 2012;177(1):118-20
Lymphoid hyperplasia and eosinophilic pneumonia as histologic manifestations of amiodarone-induced lung toxicity.
The American journal of surgical pathology. 2012;36(4):509-16
Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.
Circulation. 1982;65(4):819-24
Diffuse alveolar damage syndrome associated with amiodarone therapy.
Canadian Medical Association journal. 1983;128(10):1192-5
Amiodarone pulmonary toxicity.
Ultrastructural pathology. 1984;6(2-3):199-207
Postoperative acute respiratory distress syndrome. A complication of amiodarone associated with 100 percent oxygen ventilation.
Chest. 1992;102(3):980-1